BI-836826

DB17322InvestigationalProtein Based Therapies

BI-836826: Overview.

Mechanism: Pharmacologically active on Leukocyte antigen CD37
Curator reviewed
Also known as: ANTI-CD37 MONOCLONAL ANTIBODY BI 836826
Code names: BI-836826

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with BI-836826, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.